Susquehanna International Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Susquehanna International Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,900	Closed	-$242K	–	12998
2022 Q4	$242K	Buy	3,900 +300	+8%	+$18K	﹤0.01%	9639
2022 Q3	$203K	Buy	+3,600	New	+$222K	﹤0.01%	10800
2022 Q2	–	Sell	-3,600	Closed	-$233K	–	13357
2022 Q1	$233K	Buy	+3,600	New	+$228K	﹤0.01%	10871
2020 Q3	–	Sell	-10,200	Closed	-$523K	–	10809
2020 Q2	$523K	Sell	10,200 -7,500	-42%	-$377K	﹤0.01%	7272
2020 Q1	$794K	Buy	17,700 +8,700	+97%	+$439K	﹤0.01%	5909
2019 Q4	$480K	Buy	+9,000	New	+$444K	﹤0.01%	7064
2019 Q1	–	Sell	-17,400	Closed	-$816K	–	9307
2018 Q4	$816K	Sell	17,400 -3,300	-16%	-$169K	﹤0.01%	5072
2018 Q3	$1.16M	Sell	20,700 -2,700	-12%	-$148K	﹤0.01%	4937
2018 Q2	$1.18M	Buy	23,400 +11,100	+90%	+$550K	﹤0.01%	4998
2018 Q1	$605K	Buy	12,300 +7,500	+156%	+$385K	﹤0.01%	6246
2017 Q4	$247K	Buy	+4,800	New	+$247K	﹤0.01%	7902

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Susquehanna International Group's IHE Position: Q1 2026 in Review

Susquehanna International Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 2,129% in Q1 2026, buying an estimated $5.05M and bringing the position to 60,401 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Susquehanna International Group first reported a position in IHE in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.23M in Q2 2023. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Susquehanna International Group held 60,401 shares of iShares US Pharmaceuticals ETF worth $5.24M as of Q1 2026.
Susquehanna International Group bought 57,691 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $5.05M.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4141 holding.
Susquehanna International Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 50 quarters since.
Susquehanna International Group's iShares US Pharmaceuticals ETF position peaked at $8.23M in Q2 2023.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.